Stay updated on Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.

Latest updates to the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study page now shows a 403 Forbidden error screen with HTML indicating a forbidden access state and a Home button.SummaryDifference19%

- Check11 days agoChange DetectedThe page now displays Revision: v3.7.0, indicating an updated study document version that replaces the previous v3.6.6.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision tag has been updated from v3.6.5 to v3.6.6, indicating a small editorial update to the page's documentation/history.SummaryDifference0.0%

- Check32 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the study record, representing NIH funding metadata associated with the trial.SummaryDifference0.0%

- Check39 days agoChange DetectedThe Plain Language Summary section has been removed from the Study Details page for NCT03516981. This removal eliminates the layperson-friendly overview of the trial and its purpose from the publicly visible content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag on the page updated to v3.6.5, replacing the previous v3.6.4.SummaryDifference0.0%

Stay in the know with updates to Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.